University of Naples (Italy), November 22, 2021
People with pain of unknown causes who took alpha-lipoic acid (ALA) experienced less pain than a placebo group, a double-blind study in Biomedicine & Pharmacotherapy revealed.1 This most recent trial enrolled 210 nondiabetic men and women with mild or moderate joint pain, neuropathic pain or muscle pain of unknown cause. Participants received 800 mg or 400 mg ALA per day or a daily placebo. The results? People who received ALA had a significant improvement in their pain after two months of intake, while the placebo group didn’t report a difference. ALA was similarly effective for all sources of pain considered. It was also shown to be safe and well-tolerated.